LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article: Efficiency of Nebulizing Furosemide in the Treatment of Chronic Pulmonary Obstructive Disease: A Systematic Review and Meta-Analysis of Clinical Trials.

    Ghaysouri, Abas / Basati, Gholam / Shams, Morteza / Tavan, Hamed

    Tanaffos

    2021  Volume 19, Issue 4, Page(s) 340–349

    Abstract: Background: Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in humans. Among both oral and intravenous diuretics, nebulizing furosemide (Lasix) is the most commonly used agent. The purpose of this study was to ... ...

    Abstract Background: Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in humans. Among both oral and intravenous diuretics, nebulizing furosemide (Lasix) is the most commonly used agent. The purpose of this study was to ascertain the therapeutic effects of nebulizing furosemide compared with placebo in the treatment of COPD using a systematic review and meta-analysis of clinical trials.
    Materials and methods: This review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) protocol. The databases of Web of Science, Google Scholar, PubMed, and Scopus were independently searched by two researchers using MeSH keywords. Studies published between 2002 and 2018 in different parts of the world were considered. The meta-analysis was performed through STATA 14 software and the heterogeneity was assessed using Q statistic or I
    Results: From 40 selected articles, 8 articles were finally included in the systematic review process. The analyses were performed considering two groups; nebulizing furosemide treatment (i.e. case) and placebo (i.e. control). Based on the forest plots, the average values of PaCO
    Conclusion: nebulizing furosemide can improve and normalize the vital signs and other respiratory variables in patients with COPD.
    Language English
    Publishing date 2021-04-19
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2233372-1
    ISSN 1735-0344
    ISSN 1735-0344
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Death of a neonate with suspected coronavirus disease 2019 born to a mother with coronavirus disease 2019 in Iran: a case report.

    Rashidian, Tayebeh / Sharifi, Nasibeh / Fathnezhad-Kazemi, Azita / Mirzamrajani, Fatemeh / Nourollahi, Sajad / Ghaysouri, Abas

    Journal of medical case reports

    2020  Volume 14, Issue 1, Page(s) 186

    Abstract: Introduction: A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe ... ...

    Abstract Introduction: A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe respiratory disease. Since this virus has not previously been detected in humans, there is a paucity of information regarding its effects on humans. In addition, only limited or no information exists about its impact during pregnancy.
    Case presentation: In the present case study, we report the death of a neonate born to a 32-year-old mother with coronavirus disease 2019 in Ilam, Iran, with Kurdish ethnicity. We report the infection and death of a neonate in Iran with a chest X-ray (CXR) marked abnormality 2 hours after birth demonstrating coronavirus disease 2019 disease. The neonate was born by elective cesarean section, the fetal health was assessed using fetal heart rate and a non-stress test before the birth, and there was no evidence of fetal distress. All the above-mentioned facts and radiographic abnormalities suggested that coronavirus disease 2019 is involved.
    Conclusions: In this case study, we report the death of a neonate born to a mother with coronavirus disease 2019, 11 hours after birth. There is a paucity of data on the vertical transmission and the adverse maternal-fetal consequences of this disease, so vertical transmission from mother to child remains to be confirmed.
    MeSH term(s) Adult ; Betacoronavirus/isolation & purification ; COVID-19 ; Cesarean Section/methods ; Clinical Deterioration ; Coronavirus Infections/diagnosis ; Coronavirus Infections/physiopathology ; Coronavirus Infections/therapy ; Coronavirus Infections/transmission ; Critical Care/methods ; Fatal Outcome ; Female ; Humans ; Infant, Newborn ; Infant, Newborn, Diseases/diagnosis ; Infant, Newborn, Diseases/physiopathology ; Infant, Newborn, Diseases/therapy ; Infectious Disease Transmission, Vertical ; Iran ; Neonatal Screening/methods ; Pandemics ; Perinatal Death ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/physiopathology ; Pneumonia, Viral/therapy ; Pneumonia, Viral/transmission ; Pregnancy ; Pregnancy Complications, Infectious/diagnosis ; Pregnancy Complications, Infectious/physiopathology ; Pregnancy Complications, Infectious/therapy ; Respiration, Artificial/methods ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-10-06
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2269805-X
    ISSN 1752-1947 ; 1752-1947
    ISSN (online) 1752-1947
    ISSN 1752-1947
    DOI 10.1186/s13256-020-02519-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Recovery of an Elderly Woman with Asthma and Diabetes from COVID-19 Infection: A Case Report.

    Ghaysouri, Abas / Safari, Maryam / Mohammadyari, Elham / Balavandi, Firooz / Nazari, Ali / Feizi, Jalil / Karimian, Mohamad / Bastani, Elham / Salimi, Ebrahim / Tavan, Hamed

    Infectious disorders drug targets

    2021  Volume 21, Issue 8, Page(s) e211221191975

    Abstract: Introduction: COVID-19 has caused a great deal of fear in different communities. In this study, we reported the recovery of a diabetic elderly woman with a history of asthma from COVID-19 infection.: Case presentation: A 61-year-old woman was ... ...

    Abstract Introduction: COVID-19 has caused a great deal of fear in different communities. In this study, we reported the recovery of a diabetic elderly woman with a history of asthma from COVID-19 infection.
    Case presentation: A 61-year-old woman was hospitalized due to dyspnea and low blood O2 saturation and was later diagnosed with COVID-19, as confirmed by PCR. The patient had a history of asthma and diabetes and used salbutamol and Atrovent spray. She also had a history of hospitalization at one month prior to the current admission. Despite all these, COVID-19 was successfully managed, and she was discharged with a good clinical condition after the improvement of respiratory complications.
    Conclusion: Despite having an advanced age and underlying diseases (diabetes and asthma), the recovery of this elderly woman shows that even such patientscandefeatCOVID-19 as long as the disease is not progressed to advanced phases and appropriate therapeutic measures are taken. By reporting such cases, it is possible to give people hope and motivation and reduce their fear of the disease.
    MeSH term(s) Aged ; Asthma/complications ; Asthma/drug therapy ; COVID-19 ; Diabetes Mellitus ; Female ; Hospitalization ; Humans ; Middle Aged ; SARS-CoV-2
    Language English
    Publishing date 2021-03-02
    Publishing country United Arab Emirates
    Document type Case Reports
    ZDB-ID 2234298-9
    ISSN 2212-3989 ; 1871-5265
    ISSN (online) 2212-3989
    ISSN 1871-5265
    DOI 10.2174/1573404817666210302154129
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Death of a neonate with suspected coronavirus disease 2019 born to a mother with coronavirus disease 2019 in Iran

    Tayebeh Rashidian / Nasibeh Sharifi / Azita Fathnezhad-Kazemi / Fatemeh Mirzamrajani / Sajad Nourollahi / Abas Ghaysouri

    Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-

    a case report

    2020  Volume 5

    Abstract: Abstract Introduction A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe ...

    Abstract Abstract Introduction A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe respiratory disease. Since this virus has not previously been detected in humans, there is a paucity of information regarding its effects on humans. In addition, only limited or no information exists about its impact during pregnancy. Case presentation In the present case study, we report the death of a neonate born to a 32-year-old mother with coronavirus disease 2019 in Ilam, Iran, with Kurdish ethnicity. We report the infection and death of a neonate in Iran with a chest X-ray (CXR) marked abnormality 2 hours after birth demonstrating coronavirus disease 2019 disease. The neonate was born by elective cesarean section, the fetal health was assessed using fetal heart rate and a non-stress test before the birth, and there was no evidence of fetal distress. All the above-mentioned facts and radiographic abnormalities suggested that coronavirus disease 2019 is involved. Conclusions In this case study, we report the death of a neonate born to a mother with coronavirus disease 2019, 11 hours after birth. There is a paucity of data on the vertical transmission and the adverse maternal-fetal consequences of this disease, so vertical transmission from mother to child remains to be confirmed.
    Keywords Coronavirus 19 ; Novel coronavirus ; Infant death ; Mother-to-child transmissions ; Medicine ; R ; covid19
    Subject code 610
    Language English
    Publishing date 2020-10-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Sudden cardiac death in COVID-19 patients, a report of three cases.

    Shirazi, Samira / Mami, Sanaz / Mohtadi, Negar / Ghaysouri, Abas / Tavan, Hamed / Nazari, Ali / Kokhazadeh, Taleb / Mollazadeh, Reza

    Future cardiology

    2020  Volume 17, Issue 1, Page(s) 113–118

    Abstract: The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 ... ...

    Abstract The mortality rate of coronavirus disease-19 (COVID-19) has been reported as 1-6% in most studies. The cause of most deaths has been acute pneumonia. Nevertheless, it has been noted that cardiovascular failure can also lead to death. Three COVID-19 patients were diagnosed based on reverse transcriptase-polymerase chain reaction of a nasopharyngeal swab test and radiological examinations in our hospital. The patients received medications at the discretion of the treating physician. In this case series, chest computed tomography scans and electrocardiograms, along with other diagnostic tests were used to evaluate these individuals. Sudden cardiac death in COVID-19 patients is not common, but it is a major concern. So, it is recommended to monitor cardiac condition in selected patients with COVID-19.
    MeSH term(s) Aged ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/epidemiology ; Death, Sudden, Cardiac/etiology ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2 ; Tomography, X-Ray Computed/methods
    Keywords covid19
    Language English
    Publishing date 2020-07-03
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2274267-0
    ISSN 1744-8298 ; 1479-6678
    ISSN (online) 1744-8298
    ISSN 1479-6678
    DOI 10.2217/fca-2020-0082
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.

    Mohtadi, Negar / Ghaysouri, Abas / Shirazi, Samira / Sara Ansari / Shafiee, Elham / Bastani, Elham / Kokhazadeh, Taleb / Tavan, Hamed

    Virology

    2020  Volume 548, Page(s) 1–5

    Abstract: Introduction: During the recent months, COVID-19 has turned to a global crisis claiming high mortality and morbidity among populations. Despite the high prevalence of the disease, it has currently no definitive treatment. We here reported the effects of ...

    Abstract Introduction: During the recent months, COVID-19 has turned to a global crisis claiming high mortality and morbidity among populations. Despite the high prevalence of the disease, it has currently no definitive treatment. We here reported the effects of intravenous immunoglobulin (IVIG) administration in severely ill COVID-19 patients diagnosed based on PCR and radiology tests.
    Case presentation: Five severely ill COVID-19 patients in whom standard treatments failed were administrated with IVIG which prevented the deterioration of clinical symptoms. All the patients were treated with high-dose IVIG (0.3-0.5 g/kg) for 5 consecutive days so that no patient would receive lower than 25 g of the drug. All the patients showed a desirable therapeutic response and were discharged from the hospital with a stable clinical condition after being recovered.
    Conclusion: Treatment with IVIG at the therapeutic dose of 0.3-0.5 g/kg can improve the clinical condition and O2 saturation and prevent the progression of pulmonary lesions in COVID-19 patients with severe symptoms in whom standard treatments have failed.
    MeSH term(s) Aged ; Betacoronavirus ; Coronavirus Infections/drug therapy ; Coronavirus Infections/therapy ; Disease Progression ; Female ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Immunoglobulins, Intravenous/therapeutic use ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/drug therapy ; Pneumonia, Viral/therapy ; Treatment Outcome
    Chemical Substances Immunoglobulins, Intravenous
    Keywords covid19
    Language English
    Publishing date 2020-05-25
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 200425-2
    ISSN 1096-0341 ; 0042-6822
    ISSN (online) 1096-0341
    ISSN 0042-6822
    DOI 10.1016/j.virol.2020.05.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series

    Mohtadi, Negar / Ghaysouri, Abas / Shirazi, Samira / Shafiee, Elham / Bastani, Elham / Kokhazadeh, Taleb / Tavan, Hamed

    Virology

    Abstract: INTRODUCTION: During the recent months, COVID-19 has turned to a global crisis claiming high mortality and morbidity among populations. Despite the high prevalence of the disease, it has currently no definitive treatment. We here reported the effects of ... ...

    Abstract INTRODUCTION: During the recent months, COVID-19 has turned to a global crisis claiming high mortality and morbidity among populations. Despite the high prevalence of the disease, it has currently no definitive treatment. We here reported the effects of intravenous immunoglobulin (IVIG) administration in severely ill COVID-19 patients diagnosed based on PCR and radiology tests. CASE PRESENTATION: Five severely ill COVID-19 patients in whom standard treatments failed were administrated with IVIG which prevented the deterioration of clinical symptoms. All the patients were treated with high-dose IVIG (0.3-0.5 g/kg) for 5 consecutive days so that no patient would receive lower than 25 g of the drug. All the patients showed a desirable therapeutic response and were discharged from the hospital with a stable clinical condition after being recovered. CONCLUSION: Treatment with IVIG at the therapeutic dose of 0.3-0.5 g/kg can improve the clinical condition and O2 saturation and prevent the progression of pulmonary lesions in COVID-19 patients with severe symptoms in whom standard treatments have failed.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #361254
    Database COVID19

    Kategorien

  8. Article: Death of a neonate with suspected coronavirus disease 2019 born to a mother with coronavirus disease 2019 in Iran: a case report

    Rashidian, Tayebeh / Sharifi, Nasibeh / Fathnezhad-Kazemi, Azita / Mirzamrajani, Fatemeh / Nourollahi, Sajad / Ghaysouri, Abas

    J Med Case Rep

    Abstract: INTRODUCTION: A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe ... ...

    Abstract INTRODUCTION: A novel coronavirus named severe acute respiratory syndrome coronavirus 2, was first reported in Wuhan, China, in December 2019. The virus, known as COVID-19, is recognized as a potentially life-threatening disease by causing severe respiratory disease. Since this virus has not previously been detected in humans, there is a paucity of information regarding its effects on humans. In addition, only limited or no information exists about its impact during pregnancy. CASE PRESENTATION: In the present case study, we report the death of a neonate born to a 32-year-old mother with coronavirus disease 2019 in Ilam, Iran, with Kurdish ethnicity. We report the infection and death of a neonate in Iran with a chest X-ray (CXR) marked abnormality 2 hours after birth demonstrating coronavirus disease 2019 disease. The neonate was born by elective cesarean section, the fetal health was assessed using fetal heart rate and a non-stress test before the birth, and there was no evidence of fetal distress. All the above-mentioned facts and radiographic abnormalities suggested that coronavirus disease 2019 is involved. CONCLUSIONS: In this case study, we report the death of a neonate born to a mother with coronavirus disease 2019, 11 hours after birth. There is a paucity of data on the vertical transmission and the adverse maternal-fetal consequences of this disease, so vertical transmission from mother to child remains to be confirmed.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #818136
    Database COVID19

    Kategorien

  9. Article ; Online: Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment

    Mohtadi, Negar / Ghaysouri, Abas / Shirazi, Samira / sara Ansari / Shafiee, Elham / Bastani, Elham / Kokhazadeh, Taleb / Tavan, Hamed

    Virology

    A case series

    2020  Volume 548, Page(s) 1–5

    Keywords Virology ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 200425-2
    ISSN 1096-0341 ; 0042-6822
    ISSN (online) 1096-0341
    ISSN 0042-6822
    DOI 10.1016/j.virol.2020.05.006
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: New clinical experiences and evaluation of clinical and paraclinical features of deceased patients with COVID-19 infection referred to Shahid Mostafa Khomeini Hospital of Ilam.

    Ghaysouri, Abas / Sadeghifard, Nourkhoda / Nazari, Ali / Kalvandi, Gholamreza / Feizi, Jalil / Qasemi, Esmail / Kaffashian, Mohammad Reza / Borji, Milad / Kokhazadeh, Taleb / Tavan, Hamed

    Travel medicine and infectious disease

    2020  Volume 37, Page(s) 101657

    MeSH term(s) Aged ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/mortality ; Coronavirus Infections/pathology ; Coronavirus Infections/therapy ; Female ; Hospitalization ; Humans ; Iran/epidemiology ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/mortality ; Pneumonia, Viral/pathology ; Pneumonia, Viral/therapy ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-04-07
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 2170891-5
    ISSN 1873-0442 ; 1477-8939
    ISSN (online) 1873-0442
    ISSN 1477-8939
    DOI 10.1016/j.tmaid.2020.101657
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top